Literature DB >> 2186847

Medioventral medulla-induced locomotion.

N Kinjo1, Y Atsuta, M Webber, R Kyle, R D Skinner, E Garcia-Rill.   

Abstract

Previous anatomical studies demonstrated the presence of descending projections from the physiologically identified mesencephalic locomotor region (MLR) to the medioventral medulla (MED) in the cat. The present experiments were designed to determine if a similar low threshold locomotion-inducing area is present in the rat medulla. In addition, the nature of the neurochemical control of this area of the brain was explored using localized injections of neurochemical agents in the decerebrate rat during locomotion on a treadmill. A region virtually identical to that reported in the cat was found to lead to controlled locomotion on a treadmill following stimulation at low amplitude currents (less than or equal to 60 microA). Injections of cholinergic agonists into the MED of the rat induced locomotion which could be blocked by injections of cholinergic antagonists. In addition, injections of GABA antagonists were found to induce stepping which could be blocked by injections of GABA or GABA agonists. Substance P (SP) also was found to induce walking following injection into the MED of the rat. Injections of an excitatory amino acid agonist (NMDA) also were found to induce locomotion in the rat. These effects were blocked by injections of an excitatory amino acid antagonist (APV). Since these results had not been reported for the cat MED, a short series of experiments revealed that the MED in the cat also responded to NMDA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186847     DOI: 10.1016/0361-9230(90)90104-8

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  21 in total

1.  Is there a brainstem substrate for action selection?

Authors:  M D Humphries; K Gurney; T J Prescott
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-09-29       Impact factor: 6.237

2.  Lateral preoptic and ventral pallidal roles in locomotion and other movements.

Authors:  Suriya Subramanian; Rhett A Reichard; Hunter S Stevenson; Zachary M Schwartz; Kenneth P Parsley; Daniel S Zahm
Journal:  Brain Struct Funct       Date:  2018-04-26       Impact factor: 3.270

3.  Differential origin of reticulospinal drive to motoneurons innervating trunk and hindlimb muscles in the mouse revealed by optical recording.

Authors:  Karolina Szokol; Joel C Glover; Marie-Claude Perreault
Journal:  J Physiol       Date:  2008-09-04       Impact factor: 5.182

4.  Brainstem modulation of locomotion in the neonatal mouse spinal cord.

Authors:  Ian T Gordon; Patrick J Whelan
Journal:  J Physiol       Date:  2008-03-27       Impact factor: 5.182

5.  Locomotor speed control circuits in the caudal brainstem.

Authors:  Paolo Capelli; Chiara Pivetta; Maria Soledad Esposito; Silvia Arber
Journal:  Nature       Date:  2017-10-23       Impact factor: 49.962

6.  Fictive locomotion in the adult decerebrate and spinal mouse in vivo.

Authors:  C F Meehan; L Grondahl; J B Nielsen; H Hultborn
Journal:  J Physiol       Date:  2011-11-21       Impact factor: 5.182

Review 7.  The pedunclopontine nucleus and Parkinson's disease.

Authors:  Cecilia Tubert; Daniel Galtieri; D James Surmeier
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

8.  Involvement of the human pedunculopontine nucleus region in voluntary movements.

Authors:  E W Tsang; C Hamani; E Moro; F Mazzella; Y Y Poon; A M Lozano; R Chen
Journal:  Neurology       Date:  2010-08-11       Impact factor: 9.910

9.  Descending brain neurons in larval lamprey: spinal projection patterns and initiation of locomotion.

Authors:  Albert C Shaw; Adam W Jackson; Tamra Holmes; Suzie Thurman; G R Davis; Andrew D McClellan
Journal:  Exp Neurol       Date:  2010-05-25       Impact factor: 5.330

10.  Movement- and behavioral state-dependent activity of pontine reticulospinal neurons.

Authors:  S Thankachan; P M Fuller; J Lu
Journal:  Neuroscience       Date:  2012-07-13       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.